ScoreWhy is Cabio Biotech (Wuhan) Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 10.13%
- The company has been able to generate a Return on Capital Employed (avg) of 10.13% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 3.91% and Operating profit at -12.87% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 7.71% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 3.91% and Operating profit at -12.87% over the last 5 years
4
With a fall in Net Sales of -55.45%, the company declared Very Negative results in Jun 26
- The company has declared negative results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 144.32 MM
- NET SALES(Q) At CNY 46.58 MM has Fallen at -55.45%
- ROCE(HY) Lowest at -4.1%
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -66.54%, its profits have fallen by -65.2%
- At the current price, the company has a high dividend yield of 1.8
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cabio Biotech (Wuhan) Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Cabio Biotech (Wuhan) Co., Ltd.
-100.0%
-0.82
46.22%
China Shanghai Composite
3.23%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.91%
EBIT Growth (5y)
-12.87%
EBIT to Interest (avg)
69.13
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.32
Tax Ratio
23.59%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.62%
ROE (avg)
7.71%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
1.15
EV to EBIT
29.62
EV to EBITDA
15.84
EV to Capital Employed
1.17
EV to Sales
3.94
PEG Ratio
NA
Dividend Yield
1.85%
ROCE (Latest)
3.95%
ROE (Latest)
3.16%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-51What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 144.32 MM
NET SALES(Q)
At CNY 46.58 MM has Fallen at -55.45%
ROCE(HY)
Lowest at -4.1%
OPERATING PROFIT(Q)
Lowest at CNY -38.69 MM
PRE-TAX PROFIT(Q)
Lowest at CNY -62.59 MM
NET PROFIT(Q)
Lowest at CNY -58.55 MM
RAW MATERIAL COST(Y)
Grown by 133.37% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.24 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.25 times
INTEREST(Q)
Highest at CNY 1.3 MM
EPS(Q)
Lowest at CNY -0.34
Here's what is not working for Cabio Biotech (Wuhan) Co., Ltd.
Net Sales
At CNY 46.58 MM has Fallen at -55.45%
over average net sales of the previous four periods of CNY 104.55 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -62.59 MM has Fallen at -475.33%
over average net sales of the previous four periods of CNY 16.68 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -58.55 MM has Fallen at -521.68%
over average net sales of the previous four periods of CNY 13.88 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY 144.32 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Interest
At CNY 1.3 MM has Grown at 47.01%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Profit
Lowest at CNY -38.69 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite negative
Operating Profit (CNY MM)
Pre-Tax Profit
Lowest at CNY -62.59 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY -58.55 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
Highest at CNY 1.3 MM
in the last five periods and Increased by 47.01% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
EPS
Lowest at CNY -0.34
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Lowest at 1.24 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 1.25 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 133.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
